OPK
Income statement / Annual
Last year (2024), OPKO Health, Inc.'s total revenue was $713.14 M,
a decrease of 17.41% from the previous year.
In 2024, OPKO Health, Inc.'s net income was -$53.22 M.
See OPKO Health, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$713.14 M |
$863.50 M |
$1.00 B |
$1.77 B |
$1.44 B |
$901.90 M |
$990.30 M |
$966.01 M |
$1.22 B |
$491.70 M |
| Cost of Revenue |
$402.11 M
|
$545.37 M
|
$716.00 M
|
$1.19 B
|
$894.40 M
|
$572.50 M
|
$604.60 M
|
$620.13 M
|
$611.50 M
|
$590.20 M
|
| Gross Profit |
$311.03 M
|
$318.13 M
|
$288.20 M
|
$581.50 M
|
$541.00 M
|
$329.40 M
|
$385.70 M
|
$345.88 M
|
$610.20 M
|
-$98.50 M
|
| Gross Profit Ratio |
0.44
|
0.37
|
0.29
|
0.33
|
0.38
|
0.37
|
0.39
|
0.36
|
0.5
|
-0.2
|
| Research and Development Expenses |
$105.21 M
|
$89.59 M
|
$73.90 M
|
$76.80 M
|
$75.30 M
|
$117.90 M
|
$125.60 M
|
$126.44 M
|
$111.20 M
|
$99.49 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$304.22 M
|
$300.56 M
|
$372.70 M
|
$468.90 M
|
$355.60 M
|
$343.30 M
|
$358.40 M
|
$414.63 M
|
$490.90 M
|
$196.58 M
|
| Other Expenses |
$53.66 M
|
$85.00 M
|
$87.80 M
|
$50.30 M
|
$56.40 M
|
$64.80 M
|
-$6.00 M
|
$10.46 M
|
-$200,000.00
|
-$39.50 M
|
| Operating Expenses |
$463.10 M
|
$475.15 M
|
$534.40 M
|
$596.00 M
|
$487.30 M
|
$526.00 M
|
$551.90 M
|
$625.74 M
|
$666.50 M
|
$349.93 M
|
| Cost And Expenses |
$865.21 M
|
$1.02 B
|
$1.25 B
|
$1.79 B
|
$1.38 B
|
$1.10 B
|
$1.16 B
|
$1.25 B
|
$1.28 B
|
$590.20 M
|
| Interest Income |
$8.43 M
|
$3.98 M
|
$1.98 M
|
$28,000.00
|
$152,000.00
|
$1.71 M
|
$1.24 M
|
$610,000.00
|
$478,000.00
|
$255,000.00
|
| Interest Expense |
$47.47 M
|
$13.51 M
|
$12.06 M
|
$18.88 M
|
$21.93 M
|
$21.52 M
|
$11.89 M
|
$6.60 M
|
$7.43 M
|
$8.42 M
|
| Depreciation & Amortization |
$98.18 M
|
$105.30 M
|
$108.66 M
|
$78.72 M
|
$85.36 M
|
$93.81 M
|
$97.34 M
|
$102.09 M
|
$96.58 M
|
$42.25 M
|
| EBITDA |
$135.28 M |
-$65.52 M |
-$270.81 M |
$83.57 M |
$139.09 M |
-$189.64 M |
-$68.04 M |
-$163.23 M |
$30.46 M |
-$87.33 M |
| EBITDA Ratio |
0.19
|
-0.08
|
-0.18
|
0
|
0.07
|
-0.06
|
-0.09
|
-0.17
|
0.02
|
-0.2
|
| Operating Income Ratio |
-0.21
|
-0.18
|
-0.25
|
-0.03
|
0.04
|
-0.22
|
-0.17
|
-0.29
|
-0.06
|
-0.2
|
| Total Other Income/Expenses Net |
$141.70 M
|
-$27.30 M
|
-$165.27 M
|
-$33.40 M
|
-$9.03 M
|
-$30.91 M
|
-$6.07 M
|
$4.52 M
|
-$23.55 M
|
-$39.52 M
|
| Income Before Tax |
-$10.36 M
|
-$184.32 M
|
-$391.50 M
|
-$14.00 M
|
$48.70 M
|
-$304.90 M
|
-$177.20 M
|
-$271.92 M
|
-$73.50 M
|
-$138.00 M
|
| Income Before Tax Ratio |
-0.01
|
-0.21
|
-0.39
|
-0.01
|
0.03
|
-0.34
|
-0.18
|
-0.28
|
-0.06
|
-0.28
|
| Income Tax Expense |
$42.84 M
|
$4.44 M
|
-$63.50 M
|
$15.50 M
|
$17.60 M
|
$7.10 M
|
-$38.70 M
|
$18.86 M
|
-$56.10 M
|
-$113.70 M
|
| Net Income |
-$53.22 M
|
-$188.86 M
|
-$328.00 M
|
-$29.50 M
|
$30.59 M
|
-$312.00 M
|
-$153.00 M
|
-$305.25 M
|
-$25.10 M
|
-$30.00 M
|
| Net Income Ratio |
-0.07
|
-0.22
|
-0.33
|
-0.02
|
0.02
|
-0.35
|
-0.15
|
-0.32
|
-0.02
|
-0.06
|
| EPS |
-0.0767 |
-0.25 |
-0.46 |
-0.0455 |
0.0477 |
-0.52 |
-0.27 |
-0.55 |
-0.05 |
-0.0615 |
| EPS Diluted |
-0.0767 |
-0.25 |
-0.46 |
-0.0455 |
0.0477 |
-0.52 |
-0.27 |
-0.55 |
-0.05 |
-0.06 |
| Weighted Average Shares Out |
$694.02 M
|
$751.77 M
|
$719.06 M
|
$648.08 M
|
$640.66 M
|
$595.45 M
|
$563.14 M
|
$555.00 M
|
$502.00 M
|
$488.07 M
|
| Weighted Average Shares Out Diluted |
$694.02 M
|
$751.77 M
|
$719.06 M
|
$648.08 M
|
$640.66 M
|
$595.45 M
|
$566.67 M
|
$559.16 M
|
$502.00 M
|
$500.00 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
